Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension
- 1 February 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 341 (8842), 396-400
- https://doi.org/10.1016/0140-6736(93)92988-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trialThe Lancet, 1991
- Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertensionThe Lancet, 1990
- Prostacyclin versus thromboxane metabolite excretion: changes in pregnancy and laborEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced HypertensionNew England Journal of Medicine, 1989
- The Use of Aspirin to Prevent Ppregnancy-Induced Hypertension and Lower the Ratio of Thromboxane A2to Prostcyclin in Relatively High Risk PregnanciesNew England Journal of Medicine, 1989
- Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiencyAmerican Journal of Obstetrics and Gynecology, 1988
- Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamoleAmerican Journal of Obstetrics and Gynecology, 1987
- Low-Dose Aspirin in Prevention of Toxaemia of PregnancyDrugs, 1987
- LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAEThe Lancet, 1986
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985